If I were lucky enough to have $5,000 to invest today, I would focus on finding a handful of businesses that are building something durable, with growth supported by long-term trends.
Here are four ASX 200 shares I think offer these qualities, and I would be looking at today.
Hub24 Ltd (ASX: HUB)
Hub24 is a business that benefits from momentum. Not the kind you see in share price charts, but the kind that builds within an industry over time. Once a financial adviser adopts an investment and superannuation platform, integrates it into their workflow, and brings clients onto it, that decision tends to stick.
What I like is how that creates a layering effect. New clients are added, existing clients grow their portfolios, and over time, the platform becomes more deeply embedded in the advice process. Growth does not rely on a single catalyst; it builds gradually as the ecosystem expands.
For me, it is a business where scale can quietly do a lot of the work over the long term.
REA Group Ltd (ASX: REA)
REA Group is one of those ASX 200 shares where the product is almost unavoidable.
Anyone who has searched for property in Australia has likely interacted with its platform, and that kind of reach creates a strong position in the market.
What I like in particular is how pricing power shows up. Agents are not just paying for a listing; they are paying for visibility in a highly competitive environment. When demand for property is strong, that visibility becomes even more valuable.
It is a business that sits at the heart of real estate activity and digital advertising, and I think that combination gives it a unique ability to grow over time without needing to constantly reinvent itself.
Sigma Healthcare Ltd (ASX: SIG)
Sigma Healthcare is another ASX share I’d look at buying with the $5,000.
Following its merger with Chemist Warehouse, the business now sits across both distribution and retail, which creates a more integrated model than it had in the past.
What I find compelling is how that changes its position in the supply chain. Instead of being one step removed, the company is now more directly connected to the end customer. That can create efficiencies, improve margins, and open up new opportunities over time.
It is still early days for this combined structure, but I think the long-term potential lies in how those two sides of the business work together.
ResMed Inc (ASX: RMD)
ResMed has had a tough run, with the share price hitting a 52-week low on Friday.
That kind of move can draw attention, but what matters more to me is what is happening within the business.
ResMed operates in sleep and respiratory care, and demand in that area is closely linked to awareness and diagnosis. As more people recognise the importance of sleep health, more patients enter the system, which can support long-term growth.
As well as devices, the company has a growing software business. It is about managing patient outcomes over time, which can create a more connected and recurring relationship with users.
In my opinion, that combination of hardware and software is what makes the business stand out.
Foolish Takeaway
If I had $5,000 to invest today, I would focus on ASX 200 shares that are building long-term momentum in different ways.
Hub24 is benefiting from structural growth in platform-based investing, REA Group continues to strengthen its position in digital property advertising, Sigma Healthcare is evolving into a more integrated healthcare business, and ResMed is building a broader ecosystem around sleep and respiratory care.
I think they offer a mix of growth drivers that could play out over time and deliver attractive returns.
The post If I had $5,000 to invest in ASX 200 shares today, here’s what I’d buy appeared first on The Motley Fool Australia.
Should you invest $1,000 in HUB24 Limited right now?
Before you buy HUB24 Limited shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and HUB24 Limited wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Down 38% this year, is it finally time to buy low on CSL, ResMed and Pro Medicus shares?
- Why I’d buy these ASX 200 stocks if I were a beginner
- Buy and forget? 2 top ASX shares built for the long term
- 5 ASX growth shares to buy and hold for 5 years
- Where to invest $500 in ASX shares right now
Motley Fool contributor Grace Alvino has positions in Hub24. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Hub24 and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Hub24. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.